Suven posts fourth quarter results
Proposes a dividend of Re 0.60 per share
Suven Life Sciences announced its audited financial results for the year ended March 31,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Suven Life Sciences
Suven Life Sciences secures patents in Europe and Hong Kong
These are useful in the treatment of cognitive impairment associated with neurodegenerative disorders
Suven Life Sciences has…
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Suven initiates MAD studies in phase 1 clinical trial for investigational compound SUVN-G3031
SUVN-G3031 is a potent, selective, brain penetrant and orally active Histamine H3 inverse agonist being developed for the…
Suven Life Sciences secures two product patents
The patents from the US and New Zealand are valid until 2030 and 2031
Suven Life secures product patents from Australia, Hong Kong and Japan
The granted claims of the patents include the class of selective alpha-4-beta-two compounds discovered by Suven and are being…
Suven Life secures three product patents in Eurasia, Japan and Mexico
The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven
Suven Life Sciences raises Rs 200 cr through QIP
The company accordingly will issue 1,04,53,690 equity shares of face value of Rs 1 per equity share at a price of Rs 191.32,…
Suven Life Sciences raises Rs 200 crore through QIP
The company accordingly will issue 1,04,53,690 equity shares of face value of Re 1 per equity share at a price of Rs 191.32…
Suven begins phase I trial of NCE SUVN-G3031 in US
SUVN-G3031 is for cognition in alzheimer’s disease under US-IND 123179